The Vaccinia Virus K1L Gene Product Inhibits Host NF-κB Activation by Preventing IκBα Degradation

Journal of Virology

Volumn 78, Issue 7, 2004, Pages 3553-3560

  Shisler, Joanna L ^a   Jin, Xiao Lu ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; TUMOR NECROSIS FACTOR; VIRUS DNA; DNA; I KAPPA B; K1L PROTEIN, VACCINIA VIRUS; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; RECOMBINANT DNA; TUMOR NECROSIS FACTOR ALPHA; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DELETION MUTANT; GENE EXPRESSION REGULATION; GENE REPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; K1L GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; TRANSCRIPTION INITIATION; VACCINIA; VACCINIA VIRUS; VIRUS GENE; VIRUS GENOME; VIRUS STRAIN; VIRUS SURVIVAL; ANIMAL; BINDING SITE; CELL LINE; CLASSIFICATION; DRUG ANTAGONISM; GENETIC ENGINEERING; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PHYSIOLOGY; PROMOTER REGION; RABBIT;

ANIMALS; BINDING SITES; CELL LINE; DNA; DNA, RECOMBINANT; GENE EXPRESSION REGULATION; GENES, VIRAL; GENETIC ENGINEERING; GENOME, VIRAL; HUMANS; I-KAPPA B PROTEINS; NF-KAPPA B; PROMOTER REGIONS (GENETICS); RABBITS; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; VACCINIA VIRUS; VIRAL PROTEINS;

EID: 1842614361     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.7.3553-3560.2004     Document Type: Article

References (44)

1. Antoine, G., F. Scheiflinger, F. Dorner, and F. G. Falkner. 1998. The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses. Virology 244:365-396.
2. Baldi, L., K. Brown, G. Franzoso, and U. Siebenlist. 1996. Critical role for lysines 21 and 22 in signal-induced, ubiquitin-mediated proteolysis of I kappa B-alpha. J. Biol. Chem. 271:376-379.
3. Birbach, A., P. Gold, B. R. Binder, E. Hofer, R. de Martin, and J. A. Schmid. 2002. Signaling molecules of the NF-kappa B pathway shuttle constitutively between cytoplasm and nucleus. J. Biol. Chem. 277:10842-10851.
4. Bowie, A., E. Kiss-Toth, J. A. Symons, G. L. Smith, S. K. Dower, and L. A. O'Neill. 2000. A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling. Proc. Natl. Acad. Sci. USA 97:10162-10167.
5. Bregeon, F., A. Roch, S. Delpierre, E. Ghigo, A. Autillo-Touati, O. Kajikawa, T. R. Martin, J. Pugin, H. Portugal, J. P. Auffray, and Y. Jammes. 2002. Conventional mechanical ventilation of healthy lungs induced pro-inflammatory cytokine gene transcription. Respir. Physiol. Neurobiol. 132:191-203.
6. Brockman, J. A., D. C. Scherer, T. A. McKinsey, S. M. Hall, X. Qi, W. Y. Lee, and D. W. Ballard. 1995. Coupling of a signal response domain in IκB alpha to multiple pathways for NF-κB activation. Mol. Cell. Biol. 15:2809-2818.
7. Brooks, M. A., A. N. Ali, P. C. Turner, and R. W. Moyer. 1995. A rabbitpox virus serpin gene controls host range by inhibiting apoptosis in restrictive cells. J. Virol. 69:7688-7698.
8. Brown, K., S. Gerstberger, L. Carlson, G. Franzoso, and U. Siebenlist. 1995. Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation. Science 267:1485-1488.
9. Carlotti, F., S. K. Dower, and E. E. Qwarnstrom. 2000. Dynamic shuttling of nuclear factor kappa B between the nucleus and cytoplasm as a consequence of inhibitor dissociation. J. Biol. Chem. 275:41028-41034.
10. Carpenter, E. A., J. Ruby, and I. A. Ramshaw. 1994. IFN-gamma, TNF, and IL-6 production by vaccinia virus immune spleen cells. An in vitro study. J. Immunol. 152:2652-2659.
11. Carroll, M. W., and B. Moss. 1997. Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line. Virology 238:198-211.
12. Chaudhary, P. M., A. Jasmin, M. T. Eby, and L. Hood. 1999. Modulation of the NF-kappa B pathway by virally encoded death effector domains-containing proteins. Oncogene 18:5738-5746.
13. Chen, Z., J. Hagler, V. J. Palombella, F. Melandri, D. Scherer, D. Ballard, and T. Maniatis. 1995. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. Genes Dev. 9:1586-1597.
14. DiDonato, J., F. Mercurio, C. Rosette, J. Wu-Li, H. Suyang, S. Ghosh, and M. Karin. 1996. Mapping of the inducible IκB phosphorylation sites that signal its ubiquitination and degradation. Mol. Cell. Biol. 16:1295-1304.
15. DiDonato, J. A., M. Hayakawa, D. M. Rothwarf, E. Zandi, and M. Karin. 1997. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 388:548-554.
16. Friedman, J. M., and M. S. Horwitz. 2002. Inhibition of tumor necrosis factor alpha-induced NF-κB activation by the adenovirus E3-10.4/14.5K complex. J. Virol. 76:5515-5521.
17. Fujino, M., X. K. Li, Y. Kitazawa, L. Guo, M. Kawasaki, N. Funeshima, T. Amano, and S. Suzuki. 2002. Distinct pathways of apoptosis triggered by FTY720, etoposide, and anti-fas antibody in human T-lymphoma cell line (Jurkat cells). J. Pharmacol. Exp. Ther. 300:939-945.
18. Ghosh, S., and M. Karin. 2002. Missing pieces in the NF-κB puzzle. Cell 109(Suppl.):S81-S96.
19. Ghosh, S., M. J. May, and E. B. Kopp. 1998. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:225-260.
20. Gil, J., J. Rullas, J. Alcami, and M. Esteban. 2001. MC159L protein from the poxvirus molluscum contagiosum virus inhibits NF-κB activation and apoptosis induced by PKR. J. Gen. Virol. 82:3027-3034.
21. Harte, M. T., I. R. Haga, G. Maloney, P. Gray, P. C. Reading, N. W. Bartlett, G. L. Smith, A. Bowie, and L. A. O'Neill. 2003. The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense. J. Exp. Med. 197:343-351.
22. Haversen, L., B. G. Ohlsson, M. Hahn-Zoric, L. A. Hanson, and I. Mattsby-Baltzer. 2002. Lactoferrin down-regulates the LPS-induced cytokine production in monocytic cells via NF-kappa B. Cell. Immunol. 220:83-95.
23. Hiscott, J., H. Kwon, and P. Genin. 2001. Hostile takeovers: viral appropriation of the NF-κB pathway. J. Clin. Investig. 107:143-151.
24. Karin, M., and B. Ben-Neriah. 2000. Phosphorylation meets ubiquitination: the control of NF-⇆B activity. Annu. Rev. Immunol. 18:621-663.
25. Mercurio, F., H. Zhu, B. W. Murray, A. Shevchenko, B. L. Bennett, J. Li, D. B. Young, M. Barbosa, M. Mann, A. Manning, and A. Rao. 1997. IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation. Science 278:860-866.
26. Meyer, H., G. Sutter, and A. Mayr. 1991. Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence. J. Gen. Virol. 72:1031-1038.
27. Micheau, O., S. Lens, O. Gaide, K. Alevizopoulos, and J. Tschopp. 2001. NF-κB signals induce the expression of c-FLIP. Mol. Cell. Biol. 21:5299-5305.
28. Moss, B., and J. L. Shisler. 2001. Immunology 101 at poxvirus U: immune evasion genes. Semin. Immunol. 13:59-66.
29. Moss, B. 2001. Poxviridae: the viruses and their replication, p. 2849-2883. In D. Knipe and P. Howley (ed.), Fields virology, vol. 2. Lippincott Williams & Wilkins, Philadelphia, Pa.
30. Oie, K. L., and D. J. Pickup. 2001. Cowpox virus and other members of the orthopoxvirus genus interfere with the regulation of NF-κB activation. Virology 288:175-187.
31. Perkus, M. E., S. J. Goebel, S. W. Davis, G. P. Johnson, K. Limbach, E. K. Norton, and E. Paoletti. 1990. Vaccinia virus host range genes. Virology 179:276-286.
32. Powell, P. P., L. K. Dixon, and R. M. Parkhouse. 1996. An IκB homolog encoded by African swine fever virus provides a novel mechanism for downregulation of proinflammatory cytokine responses in host macrophages. J. Virol. 70:8527-8533.
33. Ramsey-Ewing, A. L., and B. Moss. 1996. Complementation of a vaccinia virus host-range K1L gene deletion by the nonhomologous CP77 gene. Virology 222:75-86.
34. Revilla, Y., M. Callejo, J. M. Rodriguez, E. Culebras, M. L. Nogal, M. L. Salas, E. Vinuela, and M. Fresno. 1998. Inhibition of nuclear factor κB activation by a virus-encoded IκB-like protein. J. Biol. Chem. 273:5405-5411.
35. Rokita, H., T. Kupiec, K. Guzik, and A. Koj. 1998. Vaccinia virus-regulated acute phase cytokine production in human fibroblasts, U937 cells and endothelium. Mediators Inflamm. 7:73-78.
36. Santoro, M. G., A. Rossi, and C. Amici. 2003. NF-κB and virus infection: who controls whom. EMBO J. 22:2552-2560.
37. Scherer, D. C., J. A. Brockman, Z. Chen, T. Maniatis, and D. W. Ballard. 1995. Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination. Proc. Natl. Acad. Sci. USA 92:11259-11263.
38. Shisler, J. L., and B. Moss. 2001. Molluscum contagiosum virus inhibitors of apoptosis: the MC159 v-FLIP protein blocks Fas-induced activation of procaspases and degradation of the related MC160 protein. Virology 282:14-25.
39. Slezak, K., K. Guzik, and H. Rokita. 2000. Regulation of interleukin 12 and interleukin 10 expression in vaccinia virus-infected human monocytes and U-937 cell line. Cytokine 12:900-908.
40. Smith, P. K., R. I. Krohn, G. T. Hermanson, A. K. Mallia, F. H. Gartner, M. D. Provenzano, E. K. Fujimoto, N. M. Goeke, B. J. Olson, and D. C. Klenk. 1985. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150:76-85.
41. Staib, C., I. Drexler, M. Ohlmann, S. Wintersperger, V. Erfle, and G. Sutter. 2000. Transient host range selection for genetic engineering of modified vaccinia virus Ankara. BioTechniques 28:1137-1142, 1144-. 6:1148.
42. Traenckner, E. B., H. L. Pahl, T. Henkel, K. N. Schmidt, S. Wilk, and P. A. Baeuerle. 1995. Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli. EMBO J. 14:2876-2883.
43. Willeaume, V., V. Kruys, T. Mijatovic, and G. Huez. 1995. Tumor necrosis factor-alpha production induced by viruses and by lipopolysaccharides in macrophages: similarities and differences. J. Inflamm. 46:1-12.
44. Wyatt, L. S., M. W. Carroll, C. P. Czerny, M. Merchlinsky, J. R. Sisler, and B. Moss. 1998. Marker rescue of the host range restriction defects of modified vaccinia virus Ankara. Virology 251:334-342.